Mutation in Medical Technology
Navigation Links
Mutation in Medical Technology
... advanced melanoma whose cancer harbours the BRAF mutation (known as mutation-positive ). Patients treated ... first identified we have validation that this mutation is a cancer driver and therapeutic target. In ... study of PLX4032: Proof-of-concept for V600E BRAF mutation as a therapeutic target in human Cancer."
...
... mutation Causing Mitochondrial Disease More Common Than ... finding that one in every 200 people has a DNA mutation that could potentially cause a mitochondrial ... UMDF. "We now know that 1 in 200 people carry the mutation for this horrible, debilitating disease. This ...
... experience from individuals that carry a natural mutation in their CCR5 gene suggest that permanent ... Individuals carrying a naturally occurring mutation of their CCR5 gene, a variant known as ... A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. ...
... to those who did not exhibit the gene mutation (60 percent). Among all 226 samples, quantitative ... candidate genes used in conjunction with K-Ras mutation status increases the ability to predict which ... to develop a multi-gene test comprising K-Ras mutation status in combination with the expression levels ...
... genome and can be detected with our sensitive mutation detection technology." Chief executive officer ... in disease, we are finding that mitochondrial mutation testing can provide diagnostic insights earlier ... and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated ...
... labs," added Susan Hertzberg, President of Ipsogen Inc. JAK2 V617F mutation In 2006, Ipsogen concluded a worldwide exclusive licensing ... Roussy, Paris, France. This team identified the key role played by this mutation of the JAK2 gene in the development of MPN such as Vaquez disease ...
... disease amongst Caucasian populations. The disease is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung ...
... products and services of automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
... CFTR-mediated chloride secretion in patients with a variety of nonsense mutation types, which suggests a broad spectrum of activity across one of the major ... the ability to produce functional protein across a variety of nonsense mutation types. Across all clinical studies to date, PTC124 has been generally well ...
... in an ongoing Phase 2a clinical trial for patients who carry the G551D mutation of CF. The drug is being developed by Vertex Pharmaceuticals ... in the United States and 70,000 worldwide. CF is caused by a genetic mutation that results in a malfunctioning (or missing) protein that results in an ...
... in the retina, the very back portion of the eye; they are caused by a gene mutation and occur once in every 15,000 to 16,000 births. In most cases, the mutation occurs in a single cell in the eye, so only that eye develops a tumor. ...
... myelofibrosis (IMF) and essential thrombocythemia (ET). MPL W515 L/K mutation analysis may be particularly useful for patients with suspected MPD that ... related to the launch and effectiveness of new tests, such as MPL W515 L/K mutation analysis, the utility of these tests as diagnostic tools, and the ability ...
... therapies. CML and an aggressive form of ALL share the same critical mutation -- the Philadelphia chromosome (Ph). Cells that have this mutation (Ph+ cells) produce a rogue growth-promoting enzyme called BCR-ABL. Now, ...
... spleen, lungs, brain, metabolism and bone marrow. Gaucher Disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. The disease course is quite variable, ranging from no outward symptoms to severe disability and death. Carrier status can ...
... study (abstract #9001) show the potential of Gleevec(R)(#) (imatinib mesylate) in treating patients with advanced melanoma harboring KIT mutations. A mutation in the protein called KIT, located on the surface of normal cells, signals cells to continually grow and divide. Similar KIT mutations in GIST were ...
... oxazolidinone TR-700 and linezolid; J. Locke, K. Shaw P 1104 : Characterization of the novel oxazolidinone TR-700 and linezolid spontaneous mutation frequencies and resistance mechanisms in Staphylococcus aureus ; J. Locke, K. Shaw Copies of these posters will be available on ...
... Nuernberger and his colleagues investigated the potential effect of eculizumab in two patients with aHUS, a rare disease usually caused by a genetic mutation in the complement system. In patients with aHUS, this defect results in hemolysis, formation of tiny blood clots (microvascular thrombosis) and ...
... abnormalities in the stem cell in these disorders. Greater analysis of blood cell development in myeloproliferative disorders with the JAK2 V617F mutation led researchers to identify two subsets of patients. The first subset of patients (85 percent) had an overproduction of malignant cells mainly ...
... JAK2-selective kinase inhibitor which has high potency against both the wild type JAK2 kinase and the JAK2 kinase with the V617F mutation. The V617F mutation is found in high frequencies in myeloproliferative disorders such as CIMF. It is estimated that approximately 50% of patients with CIMF possess the ...
... covering those patients who are not able to benefit from this important new treatment option as their tumors carry the KRAS mutated gene. This mutation is found in approximately 35 to 40 percent of patients with this disease. "Given that more than 95 percent of colon cancer patients ...
... (platelet-derived growth factor receptor) gene rearrangements; adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-KIT mutation or with c-KIT mutational status unknown; adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the ...
... will meet with the patient and explain the advantages, disadvantages and limitations of genetic test results. "Testing positive for a genetic mutation that predisposes you to breast cancer does not mean you will get breast cancer, and testing negative does not mean you won't get breast cancer," ...
Genetic Source of Rare Childhood Cancer Found; Gene is Implicated in Other Cancers
... blastoma (PPB) are born with a deleterious mutation in DICER1, a master controller gene that helps ... one or more cells in the lung acquire a harmful mutation in their functional copy of the DICER1 gene. ... Drs. Hill and Goodfellow uncovered an important mutation and have begun to understand the cellular mix-up ...IBT Laboratories to Launch New Pneumococcal Antibody Avidity Test at AAAAI Meeting, Booth 729
... AAAAI include the ProGenotyper (TM) Filaggrin mutation Detection Test, the latest in IBT's expanding ... atopic dermatitis or ichthyosis vugaris has a mutation that prevents the skin from working as an ... Current research suggests that patients with this mutation may benefit from targeted therapy. The new T-Cell ...PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
... trial of PTC124 in patients with nonsense mutation Duchenne and Becker muscular dystrophy ... and patients whose disease is due to a nonsense mutation represent only 13 percent of these cases, which ... trial of ataluren in patients with nonsense mutation cystic fibrosis (nmCF) in 2009. The United ...... mutation Causing Mitochondrial Disease More Common Than ... finding that one in every 200 people has a DNA mutation that could potentially cause a mitochondrial ... UMDF. "We now know that 1 in 200 people carry the mutation for this horrible, debilitating disease. This ...
... experience from individuals that carry a natural mutation in their CCR5 gene suggest that permanent ... Individuals carrying a naturally occurring mutation of their CCR5 gene, a variant known as ... A small fraction of the population carries a mutation in their CCR5 gene, called the delta32 mutation. ...
... to those who did not exhibit the gene mutation (60 percent). Among all 226 samples, quantitative ... candidate genes used in conjunction with K-Ras mutation status increases the ability to predict which ... to develop a multi-gene test comprising K-Ras mutation status in combination with the expression levels ...
... genome and can be detected with our sensitive mutation detection technology." Chief executive officer ... in disease, we are finding that mitochondrial mutation testing can provide diagnostic insights earlier ... and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated ...
Transgenomic Announces New Contracts for Phase II Trials With Two Major Pharmaceutical Companies
... to expand our selling efforts. To complement our mutation detection expertise, we also have strong capabilities in biomarker development and mutation detection in cancer pathway genes which will aid ... technologies and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated ...... labs," added Susan Hertzberg, President of Ipsogen Inc. JAK2 V617F mutation In 2006, Ipsogen concluded a worldwide exclusive licensing ... Roussy, Paris, France. This team identified the key role played by this mutation of the JAK2 gene in the development of MPN such as Vaquez disease ...
... disease amongst Caucasian populations. The disease is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung ...
Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... integrated into the nervous system of the host. The rats had a genetic mutation called SOD-1 G93A which gives them a disease similar to ALS in humans. ... cord region were grafted into the spinal cord of rats with a genetic mutation (SOD-1 G93A) that gives them a disease like a particularly aggressive form ...... products and services of automated high sensitivity genetic variation and mutation analysis. Their offerings include systems, products, discovery and ... Services utilize their technology and expertise to provide a menu of mutation scanning tests for over 700 cancer-associated genes and more than 60 ...
Presbyterian Hospital Dallas Starts Advanced Breast-Cancer Risk-Assessment Program
... of Dallas identified Elizabeth at "high risk" because she carries a mutation of the BRCA gene, which predisposes her to the disease. "So many ... how diet and exercise can lower their risk. Women who carry the BRCA gene mutation will automatically be given a breast MRI. A positive test for this ...Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections
... disease amongst Caucasian populations. The disease is caused by a mutation in the CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) gene found on chromosome 7. This mutation causes increased secretion deposits on mucous membranes. Lung ...... CFTR-mediated chloride secretion in patients with a variety of nonsense mutation types, which suggests a broad spectrum of activity across one of the major ... the ability to produce functional protein across a variety of nonsense mutation types. Across all clinical studies to date, PTC124 has been generally well ...
St. Jude Finds 'Dancing' Hair Cells Are Key to Humans' Acute Hearing
... ear, a finding that could explain how hearing loss can result from genetic mutation or overdose of drugs MEMPHIS, Tenn., May 7 /PRNewswire-USNewswire/ -- ... can result from malfunction of this amplification machinery due to genetic mutation or overdose of drugs such as aspirin. Sound entering the cochlea is ...... in an ongoing Phase 2a clinical trial for patients who carry the G551D mutation of CF. The drug is being developed by Vertex Pharmaceuticals ... in the United States and 70,000 worldwide. CF is caused by a genetic mutation that results in a malfunctioning (or missing) protein that results in an ...
Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
... primary and secondary myelofibrosis cases are believed to be caused by a mutation in the JAK2 kinase enzyme. This renders the kinase permanently active ... of Cytopia. About JAK2 The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a ...... in the retina, the very back portion of the eye; they are caused by a gene mutation and occur once in every 15,000 to 16,000 births. In most cases, the mutation occurs in a single cell in the eye, so only that eye develops a tumor. ...
Gene Hunters Fine-Tune Marker for Common Obesity Gene
... in DNA from African American children, may be a tag of an ancient mutation that first arose in Africa, where humans originated. The research ... humans originated in Africa, and this SNP may be related to an original mutation in the distant past that initiated a human predisposition to obesity. ...... myelofibrosis (IMF) and essential thrombocythemia (ET). MPL W515 L/K mutation analysis may be particularly useful for patients with suspected MPD that ... related to the launch and effectiveness of new tests, such as MPL W515 L/K mutation analysis, the utility of these tests as diagnostic tools, and the ability ...
... therapies. CML and an aggressive form of ALL share the same critical mutation -- the Philadelphia chromosome (Ph). Cells that have this mutation (Ph+ cells) produce a rogue growth-promoting enzyme called BCR-ABL. Now, ...
ARUP Laboratories Applauds FDA's Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer
... mutation-detection test can potentially eliminate ineffective patient treatment and decrease health care expenses. ARUP's technical bulletin, " KRAS mutation Detection in Colorectal Cancer; For Determining Mutational Status that Confers Resistance to Anti-EGFR Therapy ," elaborates on this testing and can ...... spleen, lungs, brain, metabolism and bone marrow. Gaucher Disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. The disease course is quite variable, ranging from no outward symptoms to severe disability and death. Carrier status can ...
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
... spleen, lungs, brain, metabolism and bone marrow. Gaucher Disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. The disease course is quite variable, ranging from no outward symptoms to severe disability and death. Carrier status can ...Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
... spleen, lungs, brain, metabolism and bone marrow. Gaucher Disease results from a specific enzyme deficiency in the body, caused by a genetic mutation received from both parents. The disease course is quite variable, ranging from no outward symptoms to severe disability and death. Carrier status can ...... study (abstract #9001) show the potential of Gleevec(R)(#) (imatinib mesylate) in treating patients with advanced melanoma harboring KIT mutations. A mutation in the protein called KIT, located on the surface of normal cells, signals cells to continually grow and divide. Similar KIT mutations in GIST were ...
Mutant Genes in High-Risk Childhood Leukemias Identified
... this subtype of ALL." The researchers discovered, in some high-risk ALL patients, that mutations in JAK appeared to work in concert with another mutation -- in the gene IKZF1 -- which they had earlier found to underlie such cases. "Our studies of these leukemia subtypes indicate that leukemia is ...BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
... consisted of patients with confirmed influenza A. Approximately 79 percent of subjects with influenza A (H1N1) demonstrated the H274Y mutation. This mutation has been associated with resistance to the anti-viral treatment oseltamivir.(2) Financial Results for the First Quarter Ended March 31, 2009 ...... oxazolidinone TR-700 and linezolid; J. Locke, K. Shaw P 1104 : Characterization of the novel oxazolidinone TR-700 and linezolid spontaneous mutation frequencies and resistance mechanisms in Staphylococcus aureus ; J. Locke, K. Shaw Copies of these posters will be available on ...
Discovery's Edge Spring Issue - http://discoverysedge.mayo.edu
... for subscription information. Parkinsonism: A Microtubule Railroad System Derailed? How Mayo researchers identified a mutation that causes a rare form of Parkinson's disease and what it means for families suffering from the condition. ...Gene Abnormality Found to Predict Childhood Leukemia Relapse
... gene and others that involve only parts of the gene. Because the genetic alterations in IKAROS in ALL are not uniform or limited to a single mutation or deletion, it may be necessary to develop a panel of different tests to detect IKAROS lesions and identify which patients are at highest risk for ...... Nuernberger and his colleagues investigated the potential effect of eculizumab in two patients with aHUS, a rare disease usually caused by a genetic mutation in the complement system. In patients with aHUS, this defect results in hemolysis, formation of tiny blood clots (microvascular thrombosis) and ...
... abnormalities in the stem cell in these disorders. Greater analysis of blood cell development in myeloproliferative disorders with the JAK2 V617F mutation led researchers to identify two subsets of patients. The first subset of patients (85 percent) had an overproduction of malignant cells mainly ...
... JAK2-selective kinase inhibitor which has high potency against both the wild type JAK2 kinase and the JAK2 kinase with the V617F mutation. The V617F mutation is found in high frequencies in myeloproliferative disorders such as CIMF. It is estimated that approximately 50% of patients with CIMF possess the ...
... covering those patients who are not able to benefit from this important new treatment option as their tumors carry the KRAS mutated gene. This mutation is found in approximately 35 to 40 percent of patients with this disease. "Given that more than 95 percent of colon cancer patients ...
Cytopia Scientific Presentations on JAK2 Inhibitor Program
... 2009. The study will be chaired by Dr Ayalew Tefferi of the Mayo Clinic, Rochester USA. About JAK2 The discovery of a specific single activating mutation in the JAK2 enzyme in MPDs in 2005 has focused attention on developing a therapy for these diseases through selective inhibition of JAK2. To ...... (platelet-derived growth factor receptor) gene rearrangements; adult patients with aggressive systemic mastocytosis (ASM) without the D816V c-KIT mutation or with c-KIT mutational status unknown; adult patients with hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL) who have the ...
... will meet with the patient and explain the advantages, disadvantages and limitations of genetic test results. "Testing positive for a genetic mutation that predisposes you to breast cancer does not mean you will get breast cancer, and testing negative does not mean you won't get breast cancer," ...
Other ContentsclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclinicalclitorisclitorisclotclotclotclotclotcobaltcobaltcobalamintartarcoalcoalcoalcoalOther TagsIgHIgHIgHIgHIgHIgHIgHATRA
(Date:11/24/2009)... This release is available in Spanish . , T...igher levels of inflammatory substances in the blo...t; as shown by a research project of the Universit..., a scientist at the School of Pharmacy. , The p...study in relation to the control of body weight an...
(Date:11/23/2009)..., Cambridge, Mass. November 23, 2009 Applied m...tain lily ( Hosta lancifolia ), a characteristic l...sely packed ripples along the edges. The simple ca... resulting from bending during differential growth... stretching foam ribbons. , Haiyi Liang, a postd...
(Date:11/23/2009)...IRVINE, Calif. -- More than 160 participants gathe...emies Keck FUTURES INITIATIVE conference. This yea...cientists, engineers, and medical researchers to e...ues surrounding the emerging field of synthetic bi...ar biology at Princeton University and this year,s...
Breaking Biology News(10 mins):It can be predicted the reaction obese patients will have to a diet 2The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process 48989 1New White Paper Helps OEM Design Engineers Navigate the Force Transducer Selection Process 48989 2Pixantrone Overview in Non Hodgkins Lymphoma to be Presented at 2009 Pan Pacific Lymphoma Conference 48985 1Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 1Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 2Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 3Phase 3 Cystic Fibrosis Trial Results Presented at European Conference 12636 4(Date:11/27/2009)...-FirstCall/ -- The Gymboree Corporation (Nasdaq: ... present at the NASDAQ OMX 23rd Investor Program, ..., England, on Wednesday, December 2, 2009, at 11:4... The Gymboree Corporation,s presentation over the ... on "Our Company" at the bottom of the page, go to...
(Date:11/27/2009)...RNewswire-FirstCall/ -- Shamir Optical Industry Lt...er of innovative products and technology to the op...rd of directors had declared a dividend distributi...ximately NIS 37.62 million based on the November 2...ximately US$ 0.609 (approximately NIS 2.3 based on...
(Date:11/27/2009)... economic burdens, study predicts , , FR...ople with diabetes in the United States is expecte...edicts. , That would bring the total by 2034 to...om 23.7 million today. , , At the same time, the..., the study also warns, rising from an estimated $...
(Date:11/27/2009)...gual coloring books designed for children ages 2 t...o educate - inform parents and children alike on a...rs to ABC,S and a host of other topics. , ...27, 2009 -- Today’s children have enough gad...ur of the day, but one of the oldest and simplest ...
(Date:11/26/2009)... With cold and flu season upon us, it,s more impor... the spread of infections and avoid illness. ,,...es healthy, but to avoid transmitting illness if w...ified in infection-control), nursing director for ...tal for Special Surgery (HSS) in Manhattan. ,, ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend[0] Diabetes Cases Expected to Double in 25 Years[2] Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books [1] Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use
soliumCCND1IgHTranslocationsSSXSYTSulfasHypoglycemicsParaglobosideGlucuronylpyogenesserotypespneumoniaeAntibodiesATRA
Other Tagssteadily 2steadily 3steadily 4steadily 5steadily 6communicable 2communicable 3communicable 4variants 2variants 3variants 4variants 5variants 6surgeon 2surgeon 3
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |